MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie.
To test the efficacy of a new amphotericin B derivative, MS-8209, in delaying scrapie, hamsters were infected intracerebrally with the 263K scrapie agent and treated with MS-8209 either early in the course of the disease or continuously. The results show that (i) all treatments lengthened the incuba...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1995
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163037/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8593027/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.12.2810 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|